Related Experiment Video
Updated: May 9, 2026
Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
Published on: February 9, 2021
Synthesis of novel psoralen analogues and their in vitro antitumor activity
Carla S Francisco1, Lígia R Rodrigues, Nuno M F S A Cerqueira
1Chemistry Centre, School of Sciences, University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal. carla.iq@gmail.com
Abstract:
New tetracyclic benzofurocoumarin (benzopsoralen) analogues were synthesized and their inhibitory effect on the growth of tumor cell lines was evaluated. The human tumor cell lines used were MDA MB231 (breast adenocarcinoma), HeLa (cervix adenocarcinoma) and TCC-SUP (bladder transitional cell carcinoma). The in vitro antitumor activity of the new benzopsoralens was discussed in terms of structure-activity relationship. Molecular docking studies with human-CYP2A6 enzymes were also carried out with the synthesized compounds in order to evaluate the potential of these compounds to interact with the heme group of the enzymes. The results have demonstrated that the linear compounds have the most pronounced activity against tumor cell lines and this might be related to the better accessibility that these compounds have to the active site in relation to the angular ones that have shown in the majority of the cases multiple binding poses in the active site of CYP2A6.
Insights
New benzopsoralen analogues show potent antitumor activity against breast, cervix, and bladder cancer cell lines. Linear compounds exhibit superior efficacy, potentially due to better enzyme active site accessibility.
Area of Science:
- Medicinal Chemistry
- Organic Synthesis
- Cancer Biology
Background:
- Benzofurocoumarins (benzopsoralens) are a class of compounds with potential therapeutic applications.
- Understanding structure-activity relationships is crucial for developing effective anticancer agents.
Purpose of the Study:
- To synthesize novel tetracyclic benzopsoralen analogues.
- To evaluate the in vitro antitumor activity of these compounds against various human tumor cell lines.
- To investigate the interaction of these compounds with human CYP2A6 enzymes using molecular docking.
Main Methods:
- Synthesis of new benzopsoralen analogues.
- In vitro cytotoxicity assays using MDA MB231, HeLa, and TCC-SUP cell lines.
- Structure-activity relationship analysis.
- Molecular docking studies against human CYP2A6.
Main Results:
- The synthesized benzopsoralen analogues displayed varying degrees of inhibitory effects on tumor cell growth.
- Linear benzopsoralen compounds demonstrated the most significant antitumor activity.
- Molecular docking revealed differential binding poses within the CYP2A6 active site, with linear compounds showing better accessibility.
Conclusions:
- Novel benzopsoralen analogues possess promising in vitro antitumor properties.
- The observed activity is linked to the structural features of the compounds, particularly their linearity.
- Enhanced accessibility to enzyme active sites may contribute to the potent anticancer effects of linear benzopsoralens.
